Adherencia al tratamiento profiláctico en pacientes hemofílicos A severos
Main Article Content
Abstract
A high adherence to prophylactic treatment in severe hemophilia patients increases and improves their quality of life. The lack of adherence to prophylactic treatment increases the chances of spontaneous hemorrhages and with them hemarthrosis and future arthropathies. Main objective: To analyze the current situation of adherence to prophylactic treatment in severe hemophilia A patients. Methodology: Our work consists of a bibliographical review of the scientific literature of the last 10 years on adherence to prophylactic treatment in severe hemophilia A patients. The search was conducted in different electronic databases. Results: Patients aged 0-12 years had the highest adherence, while lower adherence was detected in adolescent patients (13-18 years) and young adults (19-29 years). Main barriers: Patient denial of treatment, inability to understand benefits and interference with lifestyle. The evidence indicates a higher quality of life in patients with high adherence to prophylactic treatment. Conclusion: The adolescent population and the young adults present the highest risk of low adherence to prophylactic treatment, due to their transition from parental administration of the doses to the new self-infusion, due to the greater independence and freedom to decide for themselves about his illness.
References
Chan, A.K.C., Decker, K., y Warner, M. (2011). Adherence with haemophilia treatments: a survey of haemophilia healthcare professionals in Canada. Haemophilia, 17, 815-829.
De Moerloose, P., Urbancik, W., Van Den Berg, H.M., y Richards, M. (2008). A survey of adherence to haemophilia therapy in six European countries: results and recommendations. Haemophilia, 14, 931–938.
Du Treil, S., Rice, J., y Leissinger, C.A. (2007). Quantifying adherence to treatment and its relationship to quality of life in a well-characterized haemophilia population. Haemophilia, 13, 493–501.
Duncan, N., Kronenberger, W., Roberson, C., y Shapiro, A. (2010). VERITAS-Pro: a new measure of adherence to prophylactic regimens in haemophilia. Haemophilia, 16, 247–255.
Duncan, N., Shapiro, A., Ye, X., Epstein, J., y Luo, M.P. (2012). Treatment patterns, health-related quality of life and adherence to prophylaxis among haemophilia A patients in the United States. Haemophilia, 18, 760-765.
Federación Mundial de Hemofilia. (2004). ¿Quées la hemofilia?. Montreal, Canadá: Federación Mundial de Hemofilia. Recuperado de: http://www1.wfh.org/publication/files/pdf-1325.pdf
García Candel, F. (2013). Estudio descriptivo mutacional de pacientes hemofílicos en la Región de Murcia(Tesis doctoral). Universidad de Murcia, Departamento de Medicina Interna, Murcia.
Gaviria Uribe, A., Ruiz Gómez, F., Dávila Guerrero, C.E., Burgos Berna, G., Escobar Morales, G., Nates Solano, F.R., et al. (2015). Protocolo clínico para tratamiento con profilaxis de personas con hemofilia A severa sin inhibidores. Ministerio de salud y protección social. Instituto de evaluación tecnológica en salud. Recuperado de: https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/DE/CA/Protocolo-hemofilia-marzo-2015.pdf
Geraghty, S., Dunkley, T., Harrington, C., Lindvall, K., Maahs, J., y Sek, J. (2006). Practice patterns in haemophilia A therapy –global progress towards optimal care. Haemophilia, 12, 75–81.
Khair, K. (2010). Minimizing Joint Damage, the role of nurses in promoting adherence to hemophilia treatment. Orthopaedic Nursing, 29(3), 193-202.
Mclaughlin, J.M., Witkop, M.L., Lambing, A., Anderson, T.L., Munn, J., y Tortella, B. (2014). Bettter adherence to prescribed treatment regimen is related to less chronic pain among adolescents and young adults with moderate or severe haemophilia.Haemophilia, 1-7.
Ono, O., Suzuki, Y., Yosikawa, K., Wada, I., Doi, Y., Takano, M., et al. (2009). Assessment of haemophilia treatment practice pattern in Japan. Haemophilia, 15, 1032-1038.
Organización Mundial de la Salud, Sabaté, E. (2004). Adherencia a los tratamientos a largo plazo: pruebas para la acción. Ginebra, Suiza: Organización Mundial de la Salud. Recuperado de:http://www.paho.org/hq/index.php?option=com_docman&task=doc_view&gid=18722&Itemid
Remor, E. (2011). Predictors of treatment difficulties and satisfaction with haemophilia therapy in adult patients. Haemophilia, 17, 901–905.
Schrijvers, L.H., Uitslager, N., Schuurmans, M.J., y Fischer, K. (2013). Barriers and motivators of adherence to prophylactic treatment in haemophilia: a systematic review. Haemophilia, 19, 355-361.
Srivastava, A., Brewer, A.K., Mauser Bunschoten, E.P., Key, N.S., Kitchen, S., Llinás, A., et al. (2012). Guía para el tratamiento de la hemofilia. 2ªed. Montreal, Canadá: Federación Mundial de Hemofilia. Recuperado de: http://www1.wfh.org/publication/files/pdf-1513.pdf
Thornburg, C.D. (2008). Physicians’ perceptions of adherence to prophylactic clotting factor infusions. Haemophilia, 14, 25–29.
Thornburg, C.D. (2010). Prophylactic factor infusion for patients with hemophilia: challenges with treatment adherence. J Coagul Disord, 2, 9–14.
Thornburg, C.D., Carpenter, S., Zappa, S., Munn, J., y Leissinger, C. (2012). Current prescription of prophylactic factor infusions and perceived adherence for children and adolescents with haemophilia: a survey of haemophilia healthcare professionals in the United States. Haemophilia, 18, 568-574.
Zappa, S., McDaniel, M., Marandola, J., Allen, G. (2012). Treatment trends for haemophilia A and haemophilia B in the United States: results from the 2010 practice patterns survey. Haemophilia, 18, 140-153.